How this site works
Editorial policy
The rules we hold ourselves to when we read the research, rank a provider, and take a commission.
Microdosing is off-label and unproven, and we say so everywhere
There are no dedicated randomized trials of intentionally sub-therapeutic GLP-1 dosing. Everything published here about microdosing is extrapolated from dose-response data at approved doses, from compounding-pharmacy practice and from clinician experience — not from evidence that low-dose GLP-1 delivers the outcomes seen at label doses. That caveat sits beside every call-to-action on this site, on every card, partner or not, and no commercial relationship is allowed to soften it. Compounded GLP-1 medication is also not an FDA-approved product. Start with our evidence review before you read any ranking.
How the provider ranking is funded
On our provider ranking, some of the providers pay us a commission when a reader starts through our link. That is stated at the top of the ladder itself, not only here. It does buy position: our featured partner comes first, then the other providers that pay us, then everyone else, and inside each group the order is set by hand — there is no score behind it. What it does not buy is a softer write-up: price transparency, clinical oversight, included support and the compounding route are printed on every card the same way, so you can judge the argument rather than trust the position. Full detail in our funding disclosure.
Partners and non-partners get the same treatment on the page
Every provider we rank gets a price line, a plain-language summary, a strengths list, a trade-offs list and an outbound button that looks exactly the same. Partner links route through our own /go redirect and carry rel="sponsored"; non-partner links take the same redirect to the provider's own site and are never marked sponsored. The ranking is not a survey of the whole market — it is the GLP-1 providers we have read, including the many that sell only a standard plan with no separate low-dose option, which the card says.
Sourcing, prices and corrections
In our evidence articles, every medical or efficacy claim is tied to a primary source — peer-reviewed research or official FDA labeling — and cited inline, including null results. Provider reviews are written from each company's own published pages: its prices, its terms and how it describes its program. Prices are stated only where a provider published one we could confirm; where pricing is gated behind an eligibility request, the card says so rather than guessing. Terms change without notice, so confirm with the provider before starting. If something here is wrong, email care@lowdoseglp1.com and we will correct it and note the change. Everything here is written under the pen name Lena Ortiz, whose page sets out what that name does and does not stand for.
This is not medical advice
Nothing here diagnoses, treats or prescribes, and none of our calculators sets a dose. GLP-1 medication — at any dose — is a prescription decision with real side effects, screening requirements and ongoing cost. Make it with a licensed clinician.